secwatch / observer
8-K filed October 6, 2023, 7:59 PM ET CIK 0001729750
other material confidence high sentiment negative materiality 0.65

Kubient, Inc.: restructuring charge — Kubient cuts workforce 36%, terminates CPO Zemel, expects $320K restructuring charges

Kubient, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Leon Zemel

Chief Products Officer
Kubient, Inc.
Effective
2023-10-02
Filed
October 6, 2023, 7:59 PM ET
the Company terminated the employment of Leon Zemel as Chief Products Officer of the Company without cause.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Leon Zemel was terminated as Chief Products Officer at Kubient, Inc..

Action
terminated
Role
Chief Products Officer
Exact text from the filing
the Company terminated the employment of Leon Zemel as Chief Products Officer of the Company without cause.
View on SEC.gov
Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

Kubient, Inc. announced a restructuring with charges of approximately $320,000 (approximately 36% reduction in the Company’s workforce , or 4 people).

Type
restructuring
Charge
approximately $320,000
Headcount
approximately 36% reduction in the Company’s workforce , or 4 people
Exact text from the filing
in connection with the workforce reduction plan with respect to severance payments and benefits. Severance and benefit continuation charges are estimated to be approximately $320,000 and are expected to be recognized primarily in the fourth quarter of 2023. The Company expects the organizational change will reduce current annualized payroll and benefit
View on SEC.gov

Browse all restructurings & charges →

Source: SEC EDGAR
accession 0001140361-23-047397
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.